REFERENCES
- Georgopapadakou NH, Tkacz JS. The fungal cell wall as a drug target. Trends Microbiol 1995; 3: 98–104.
- Lynch ME, Sobel JD. Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeasts isolates. J Med Vet Mycol 1994; 32: 267–74.
- Palacin C, Sacristan A, Ortiz JA. In vitro comparative study of the fungistatic and fungicidal activity of sertaconazole and other antifungals against Candida albicans. Arzneim Forch 1992; 42: 711–14.
- Sobel JD. Vulvovaginitis. When Candida becomes a problem. Dermatol Clin 1998; 16: 763–68.
- Brundin J. The effect of miconazole on vulvovaginal candidosis in pregnant and non-pregnant women and their partners. Int J Gynecol Obstet 1976; 14: 537–40.
- Carrillo-Munoz AJ, Torres Rodriguez JM. In-vitro anti-fungal activity of sertaconazole, econazole and bifonazole against Candida spp. J Antimicrob Chemother 1995; 36: 713–16.
- Schar G, Kayer FH, Dupont MC. Antimicrobial activity of econazole and miconazole in vitro and in experimental candidiasis and aspergillosis. Chemotherapy 1976; 22: 221–27.
- Strippoli V, D'Auria FD, Simonetti N. In vitro antimicro-bial activity of econazole and miconazole sulfosalicylate. Drugs Expll Clin Res 1990; 16: 237–42.
- Heel RC, Brogden RN, Speight TM, Avery GS. Econazole: a review of its antifungal activity and therapeutic efficacy. Drugs 1978; 16: 177–201.
- Bogle RG, Valiance P. Functional effects of econazole on inducible nitric oxide synthase: production of a calmodulin-dependent enzyme. Br J Pharmacol 1996; 117: 1053–8.
- Sanyal AK, Roy D, Chowdhury B, Banerjee AB. Ibuprofen, a unique anti-inflammatory compound with antifun-gal activity against dermatophytes. Lett Appl Microbiol 1993; 17: 109–11.
- Elvers KT Wright SJL. Antibacterial activity of the anti-inflammatory compound ibuprofen. Lett Appl Microbiol 1990; 20: 82–4.
- Hersh EV, Hammond BF, Fleury AA. Antimicrobial activity of flurbiprofen and ibuprofen in vitro against six com-mon periodontal pathogens. J Clin Dent 1991; 3: 1–5.
- Drago L, Tocalli L, Fassina MC, Mombelli B, De Vecchi E, Gismondo MR. Attività antimicrobica di ibuprofene isobutanolammonio nei confronti di germi isolati da campioni vaginali. Farmaci Terapia 1999; XVI: 16-21.
- Polak A. Combination therapy in systemic mycosis. J Chemother 1990; 2: 211–17.
- Scott EM, Tariq VN, McCrory RM. Demonstration of synergy with fluconazole and either ibuprofen, sodium saucy-late or propylparaben against Candida albicans in vitro. Antimicrob Agents Chemother 1995; 39: 2610–14.
- Tariq VN, Scott. EM, McCain NE. Use of decimal assay for additivity to demonstrate synergy in pair combinations of econazole, nikkomycin Z, and ibuprofen against Candida albi-cans in vitro. Antimicrob Agents Chemother 1995; 39: 2615–9.
- Abramson S, Edelson HS, Kaplan HB, Ludewig R, Weissman G. Inhibition of neutrophil activation by nons-teroidal anti-inflammatory drugs. Am J Med 1984; 77: 3–6.
- Kaplan HB, Edelson HS, Korchak HM, Given WP, Abramson S, Weissman G. Effects of non-steroidal antiinflam-matory agents on human neutrophil functions in vitro and in vivo. Biochem Pharmacol 1984; 33: 371–8.
- Witkin SS, Hirsch J, Ledger WJ. A macrophage defect in women with recurrent Candida vaginitis and its reversal in vitro by prostaglandin inhibitors. Am J Obstet Gynecol 1986; 155: 790–5.
- Georgopapadakou NH, Dix BA, Smith SA, Freudenberger J, Funke PT. Effect of antifungal agents on lipid biosynthesis and membrane integrity in Candida albi-cans. Antimicrob Agents Chemother 1987; 31: 46–51.
- Bastide M, Jouvert S, Bastide JM. A comparison of the effects of several antifungal imidazole derivatives and polyenes on Candida albicans: an ultrastructural study by scanning electron microscopy. Can J Microbiol 1982; 28: 1119–26.